ArticleThe Journal of infectious diseases2025
CDC-Funded HIV Testing Services Outcomes in Ending the HIV Epidemic in the U.S. (EHE) and Non-EHE Jurisdictions, 2021.
Article in The Journal of infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- NIH Investment in HIV and Implementation Science.Journal of the International AIDS Society · 2026Article
- HIV and Syphilis Testing Among Patients Tested for Gonorrhea and Chlamydia in Emergency Departments.The western journal of emergency medicine · 2026Observational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
background"Ending the HIV Epidemic in the US" (EHE) focuses on 57 jurisdictions most affected by HIV.
methodsUsing 2021 data from the National HIV Prevention Program Monitoring and Evaluation system, we calculated distributions of Centers for Disease Control and Prevention-funded HIV tests and HIV testing services outcomes in EHE and non-EHE jurisdictions. We conducted χ2 tests and robust Poisson regression to compare differences in outcomes.
resultsOf the 1 753 873 tests, a greater proportion was conducted in EHE (65.7%) vs non-EHE (34.3%) jurisdictions (P < .001). A greater number of persons newly diagnosed were in EHE (n = 5861) vs non-EHE (n = 2329) jurisdictions; newly diagnosed positivity was also higher in EHE (0.5%) vs non-EHE (0.4%) jurisdictions (prevalence ratio [PR], 1.31; 95% CI, 1.25-1.38). Among persons newly diagnosed, there were no differences in linkage to care within 30 days in EHE (77.9%) vs non-EHE (77.1%) jurisdictions (PR, 1.01; 95% CI, .95-1.07). The proportion of persons newly diagnosed interviewed for partner services was lower in EHE (69.0%) vs non-EHE (84.8%) jurisdictions (PR, 0.81; 95% CI, .76-.87).
conclusionsCenters for Disease Control and Prevention-funded HIV testing services in EHE jurisdictions conducted more HIV testing and diagnosed more persons. Jurisdictions can further expand HIV testing and related services to continue striving toward EHE goals.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.